Abstract
The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global public health crisis. Many reports indicate disappointing results in cancer patients compared to the general population. Therefore, experts in the management of oncohematological malignancies from the National Institute of Neoplastic Diseases, national hospitals and a private clinic in Metropolitan Lima have developed recommendations obtained by consensus to continue with the management of patients with oncohematological neoplasms safely in the face of the pandemic.
| Translated title of the contribution | Management of oncohematological neoplasms in the COVID-19 pandemic: Experts recommendation |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 161-168 |
| Number of pages | 8 |
| Journal | Anales de la Facultad de Medicina |
| Volume | 82 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1 Jan 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Manejo de neoplasias oncohematológicas en el contexto de la pandemia de COVID-19: Recomendación de expertos'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver